Picture EBD Group BioPharm America 2020 Digital Event BEU2020 650x81
Financing › Details

Kandy Therapeutics–Bayer: investment, 202008– acquisition $425m upfront + $450m developm milestones + triple digit $m sales milestones


Period Period 2020-08-11
Organisations Money taker Kandy Therapeutics Ltd.
  Money source Bayer Pharma AG
  Group Bayer (Group)
Products Product NT-814 (NeRRe Therapeutics / KaNDy Therapeutics)
  Product 2 women’s health
Document Source Bayer AG. (8/11/20). "Press Release: Bayer to Acquire UK-based Biotech Kandy Therapeutics Ltd. [Not intended for U.S. and UK Media]". Berlin.

Record changed: 2020-09-10


Picture [iito] No Tracking 650x80px

More documents for Kandy Therapeutics Ltd.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top